Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Filings indexed 961 across all filing types
Latest filing 2026-05-14 Legal Proceedings Report
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Legal Proceedings Report Classification · 95% confidence The document is a SEBI Listing Obligations disclosure under Regulation 30 announcing receipt of a demand notice from the National Pharmaceutical Pricing Authority. It reports a regulatory/legal action rather than financial results, board changes, or shareholder matters. This fits “Legal Proceedings Report” (LTR) as it details a regulatory order and its impact.
2026-05-14 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 85% confidence The document is a stock exchange filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides a compliance disclosure of a demand notice received from the National Pharmaceutical Pricing Authority. It is not an earnings release, management report, board change, or detailed financial report. This type of miscellaneous regulatory announcement fits the 'Regulatory Filings' fallback category.
2026-05-14 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-29 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-09 English
Trading Window
Regulatory Filings
2026-03-31 English
Shareholders meeting
Regulatory Filings
2026-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.